• share
• favorite_border

Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection with 99.9% to 100% efficacy and could dramatically lower infection rates worldwide.

• share
• favorite_border

• share
• favorite_border

FAU researchers have been awarded a five-year NIH grant to address the urgent need for a reliable, rapid and affordable self-test for early HIV detection. Expected to cost less than $5, the novel micro-chip technology will detect HIV during the acute infection phase or viral rebound, deliver rapid results in about 40 minutes and remain stable without refrigeration.

• share
• favorite_border

Two researchers from the Johns Hopkins University School of Medicine have been elected 2024 Fellows of the American Association for the Advancement of Science (AAAS), the largest scientific society in the world and publisher of the Science family of journals.

• share
• favorite_border

• share
• favorite_border

Researchers at Washington University in St. Louis use AI to target HIV treatment interventions to improve compliance.

• share
• favorite_border

Protein crystallization at the SER-CAT beamline at Argonne鈥檚 Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

• share
• favorite_border

Colby Maldini, Ph.D., who joins Wistar鈥檚 HIV Cure and Viral Diseases Center as a Caspar Wistar Fellow

• share
• favorite_border

Researchers engineered a paper device with wax-printed patterns that collect precise volumes of blood, which can be used for sample collection at remote locations across the globe. A clinical pilot demonstrated significantly improved detection of HIV over current standard methods.

• share
• favorite_border

Masimirembwa, a Distinguished Professor at Wits University's Sydney Brenner Institute for Molecular Bioscience (SBIMB), received the award at a ceremony in California, USA, on 7 February. The PMWC Pioneer Award recognises Masimirembwa鈥檚 groundbreaking work in pharmacogenomics, shedding light on how genetic differences influence drug responses across diverse populations.

• share
• favorite_border

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real-time isothermal amplification.

• share
• favorite_border

Rutgers Health experts discuss the pressing issues in HIV treatment and prevention

• share
• favorite_border

Combining bupropion medication and a behavioral counseling program dramatically increased quit rates among people living with HIV who smoked.

• share
• favorite_border

Researchers at The Wistar Institute鈥檚 HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach 鈥淣uKES鈥�: Natural Killer Enhancement Strategy.

• share
• favorite_border

How the HIV inserts its capsid into the host cell鈥檚 nuclear pore is a puzzle and a therapeutic target. Simulations on the Pittsburgh Supercomputing Center鈥檚 Bridges-2 system by a University of Pittsburgh team revealed how changes in the shape of the HIV-1 capsid protein may help the capsid be more flexible.

• share
• favorite_border

Nicolas Chomont and Andr茅s Finzi will use the CIHR funds to work to develop a treatment capable of permanently eliminating the human immunodeficiency virus from the body.

• share
• favorite_border